Skip to main content
Premium Trial:

Request an Annual Quote

Bruker s Revenues Rise 10 Percent, Earnings Stay Flat in Q1

NEW YORK, May 6 (GenomeWeb News) - Bruker BioSciences yesterday reported a 10-percent increase in revenues and flat earnings for the first quarter of 2005.

 

Revenues for the quarter were $74.9 million, up from $68.2 million during the first quarter of 2004. Bruker Daltonics, Bruker's mass spectrometry operating business that includes instruments used for proteomics, contributed $42.6 million to total revenues, a 10-percent increase over last year's revenues. $29.8 million of the unit's revenues came from sales of life-science mass spectrometry systems.

 

Research and development expenses increased to $11 million from $9.9 million during the same quarter last year.

 

The company's net income fell to $400,000, or $0 per share, from $500,000, or $.01 per share, during the same period a year ago.

 

As of March 31, Bruker BioSciences had $84.8 million in cash and short-term investments.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.